Asia Green Biotechnology (XCNQ:ASIA) ROCE % : 0.00% (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Asia Green Biotechnology ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Asia Green Biotechnology's annualized ROCE % for the quarter that ended in Mar. 2024 was 0.00%.

Asia Green Biotechnology ROCE % Historical Data

The historical data trend for Asia Green Biotechnology's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asia Green Biotechnology ROCE % Chart

Asia Green Biotechnology Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-104.60

-80.20

-215.23

Asia Green Biotechnology Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															-	-	-	-	-

Asia Green Biotechnology ROCE % Calculation

Asia Green Biotechnology's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-0.191	/	( ( (0.068 - 0.249)	+	(0.065 - 0.527) )	/ 2 )
	=	-0.191	/	( (-0.181	+	-0.462)	/ 2 )
	=	-0.191	/	-0.3215
	=	59.41 %

Asia Green Biotechnology's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	-0.152	/	( ( (0.065 - 0.527)	+	(0.067 - 0.575) )	/ 2 )
	=	-0.152	/	( ( -0.462	+	-0.508 )	/ 2 )
	=	-0.152	/	-0.485
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Asia Green Biotechnology (XCNQ:ASIA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Asia Green Biotechnology ROCE % Related Terms

Thank you for viewing the detailed overview of Asia Green Biotechnology's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Asia Green Biotechnology (XCNQ:ASIA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Asia Green Biotechnology Corp (XCNQ:ASIA) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

707 - 7th Avenue SW, Suite 1150, Calgary, AB, CAN, T2P 3H6

Website

https://www.asiagreenbiotechnology.com

Asia Green Biotechnology Corp is an early stage international agri-technology company focused on the development, evaluation, testing, application and, ultimately, supply to the market of proprietary organic hybridization technology and certain products derived from that technology. The core approach of the business is centred on the planting, growth and harvesting of new and valuable strains of hemp and related crops in commercial quantities. The company is developing varieties of hemp with superior growth and production characteristics in the various environments found in the licensed territories.

Executives

Johannes Kingma

Senior Officer